 | • レポートコード：MRC2-11QY02618 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はアピキサバンのグローバル市場について調査・分析したレポートです。種類別（カプセル、タブレット）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別アピキサバンの競争状況、市場シェア ・世界のアピキサバン市場：種類別市場規模 2015年-2020年（カプセル、タブレット） ・世界のアピキサバン市場：種類別市場規模予測 2021年-2026年（カプセル、タブレット） ・世界のアピキサバン市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界のアピキサバン市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米のアピキサバン市場分析：米国、カナダ ・ヨーロッパのアピキサバン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのアピキサバン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のアピキサバン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのアピキサバン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Medichem、Polpharma、Beijing Cooperate Pharmaceutical、Centaur Pharmaceutical、DEAFARMA、Dipharma Francis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Apixaban Market
The global Apixaban market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Apixaban Scope and Market Size
Apixaban market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Apixaban market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Apixaban market is segmented into
Capsule
Tablet
Segment by Application, the Apixaban market is segmented into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regional and Country-level Analysis
The Apixaban market is analysed and market size information is provided by regions (countries).
The key regions covered in the Apixaban market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Apixaban Market Share Analysis
Apixaban market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Apixaban business, the date to enter into the Apixaban market, Apixaban product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Medichem
Polpharma
Beijing Cooperate Pharmaceutical
Centaur Pharmaceutical
DEAFARMA
Dipharma Francis
…
1 Study Coverage
1.1 Apixaban Product Introduction
1.2 Market Segments
1.3 Key Apixaban Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Apixaban Market Size Growth Rate by Type
1.4.2 Capsule
1.4.3 Tablet
1.5 Market by Application
1.5.1 Global Apixaban Market Size Growth Rate by Application
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Apixaban Market Size, Estimates and Forecasts
2.1.1 Global Apixaban Revenue 2015-2026
2.1.2 Global Apixaban Sales 2015-2026
2.2 Global Apixaban, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Apixaban Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Apixaban Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Apixaban Competitor Landscape by Players
3.1 Apixaban Sales by Manufacturers
3.1.1 Apixaban Sales by Manufacturers (2015-2020)
3.1.2 Apixaban Sales Market Share by Manufacturers (2015-2020)
3.2 Apixaban Revenue by Manufacturers
3.2.1 Apixaban Revenue by Manufacturers (2015-2020)
3.2.2 Apixaban Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Apixaban Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Apixaban Revenue in 2019
3.2.5 Global Apixaban Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Apixaban Price by Manufacturers
3.4 Apixaban Manufacturing Base Distribution, Product Types
3.4.1 Apixaban Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Apixaban Product Type
3.4.3 Date of International Manufacturers Enter into Apixaban Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Apixaban Market Size by Type (2015-2020)
4.1.1 Global Apixaban Sales by Type (2015-2020)
4.1.2 Global Apixaban Revenue by Type (2015-2020)
4.1.3 Apixaban Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Apixaban Market Size Forecast by Type (2021-2026)
4.2.1 Global Apixaban Sales Forecast by Type (2021-2026)
4.2.2 Global Apixaban Revenue Forecast by Type (2021-2026)
4.2.3 Apixaban Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Apixaban Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Apixaban Market Size by Application (2015-2020)
5.1.1 Global Apixaban Sales by Application (2015-2020)
5.1.2 Global Apixaban Revenue by Application (2015-2020)
5.1.3 Apixaban Price by Application (2015-2020)
5.2 Apixaban Market Size Forecast by Application (2021-2026)
5.2.1 Global Apixaban Sales Forecast by Application (2021-2026)
5.2.2 Global Apixaban Revenue Forecast by Application (2021-2026)
5.2.3 Global Apixaban Price Forecast by Application (2021-2026)
6 North America
6.1 North America Apixaban by Country
6.1.1 North America Apixaban Sales by Country
6.1.2 North America Apixaban Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Apixaban Market Facts & Figures by Type
6.3 North America Apixaban Market Facts & Figures by Application
7 Europe
7.1 Europe Apixaban by Country
7.1.1 Europe Apixaban Sales by Country
7.1.2 Europe Apixaban Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Apixaban Market Facts & Figures by Type
7.3 Europe Apixaban Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Apixaban by Region
8.1.1 Asia Pacific Apixaban Sales by Region
8.1.2 Asia Pacific Apixaban Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Apixaban Market Facts & Figures by Type
8.3 Asia Pacific Apixaban Market Facts & Figures by Application
9 Latin America
9.1 Latin America Apixaban by Country
9.1.1 Latin America Apixaban Sales by Country
9.1.2 Latin America Apixaban Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Apixaban Market Facts & Figures by Type
9.3 Central & South America Apixaban Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Apixaban by Country
10.1.1 Middle East and Africa Apixaban Sales by Country
10.1.2 Middle East and Africa Apixaban Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Apixaban Market Facts & Figures by Type
10.3 Middle East and Africa Apixaban Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Apixaban Products Offered
11.1.5 Pfizer Related Developments
11.2 Medichem
11.2.1 Medichem Corporation Information
11.2.2 Medichem Description and Business Overview
11.2.3 Medichem Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Medichem Apixaban Products Offered
11.2.5 Medichem Related Developments
11.3 Polpharma
11.3.1 Polpharma Corporation Information
11.3.2 Polpharma Description and Business Overview
11.3.3 Polpharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Polpharma Apixaban Products Offered
11.3.5 Polpharma Related Developments
11.4 Beijing Cooperate Pharmaceutical
11.4.1 Beijing Cooperate Pharmaceutical Corporation Information
11.4.2 Beijing Cooperate Pharmaceutical Description and Business Overview
11.4.3 Beijing Cooperate Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Beijing Cooperate Pharmaceutical Apixaban Products Offered
11.4.5 Beijing Cooperate Pharmaceutical Related Developments
11.5 Centaur Pharmaceutical
11.5.1 Centaur Pharmaceutical Corporation Information
11.5.2 Centaur Pharmaceutical Description and Business Overview
11.5.3 Centaur Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Centaur Pharmaceutical Apixaban Products Offered
11.5.5 Centaur Pharmaceutical Related Developments
11.6 DEAFARMA
11.6.1 DEAFARMA Corporation Information
11.6.2 DEAFARMA Description and Business Overview
11.6.3 DEAFARMA Sales, Revenue and Gross Margin (2015-2020)
11.6.4 DEAFARMA Apixaban Products Offered
11.6.5 DEAFARMA Related Developments
11.7 Dipharma Francis
11.7.1 Dipharma Francis Corporation Information
11.7.2 Dipharma Francis Description and Business Overview
11.7.3 Dipharma Francis Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Dipharma Francis Apixaban Products Offered
11.7.5 Dipharma Francis Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Apixaban Products Offered
11.1.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Apixaban Market Estimates and Projections by Region
12.1.1 Global Apixaban Sales Forecast by Regions 2021-2026
12.1.2 Global Apixaban Revenue Forecast by Regions 2021-2026
12.2 North America Apixaban Market Size Forecast (2021-2026)
12.2.1 North America: Apixaban Sales Forecast (2021-2026)
12.2.2 North America: Apixaban Revenue Forecast (2021-2026)
12.2.3 North America: Apixaban Market Size Forecast by Country (2021-2026)
12.3 Europe Apixaban Market Size Forecast (2021-2026)
12.3.1 Europe: Apixaban Sales Forecast (2021-2026)
12.3.2 Europe: Apixaban Revenue Forecast (2021-2026)
12.3.3 Europe: Apixaban Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Apixaban Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Apixaban Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Apixaban Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Apixaban Market Size Forecast by Region (2021-2026)
12.5 Latin America Apixaban Market Size Forecast (2021-2026)
12.5.1 Latin America: Apixaban Sales Forecast (2021-2026)
12.5.2 Latin America: Apixaban Revenue Forecast (2021-2026)
12.5.3 Latin America: Apixaban Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Apixaban Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Apixaban Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Apixaban Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Apixaban Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Apixaban Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Apixaban Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Apixaban Market Segments
Table 2. Ranking of Global Top Apixaban Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Apixaban Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Capsule
Table 5. Major Manufacturers of Tablet
Table 6. Global Apixaban Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Apixaban Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Apixaban Sales by Regions 2015-2020 (K MT)
Table 9. Global Apixaban Sales Market Share by Regions (2015-2020)
Table 10. Global Apixaban Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Apixaban Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Apixaban Sales Share by Manufacturers (2015-2020)
Table 13. Global Apixaban Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Apixaban by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Apixaban as of 2019)
Table 15. Apixaban Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Apixaban Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Apixaban Price (2015-2020) (USD/MT)
Table 18. Apixaban Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Apixaban Product Type
Table 20. Date of International Manufacturers Enter into Apixaban Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Apixaban Sales by Type (2015-2020) (K MT)
Table 23. Global Apixaban Sales Share by Type (2015-2020)
Table 24. Global Apixaban Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Apixaban Revenue Share by Type (2015-2020)
Table 26. Apixaban Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Apixaban Sales by Application (2015-2020) (K MT)
Table 28. Global Apixaban Sales Share by Application (2015-2020)
Table 29. North America Apixaban Sales by Country (2015-2020) (K MT)
Table 30. North America Apixaban Sales Market Share by Country (2015-2020)
Table 31. North America Apixaban Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Apixaban Revenue Market Share by Country (2015-2020)
Table 33. North America Apixaban Sales by Type (2015-2020) (K MT)
Table 34. North America Apixaban Sales Market Share by Type (2015-2020)
Table 35. North America Apixaban Sales by Application (2015-2020) (K MT)
Table 36. North America Apixaban Sales Market Share by Application (2015-2020)
Table 37. Europe Apixaban Sales by Country (2015-2020) (K MT)
Table 38. Europe Apixaban Sales Market Share by Country (2015-2020)
Table 39. Europe Apixaban Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Apixaban Revenue Market Share by Country (2015-2020)
Table 41. Europe Apixaban Sales by Type (2015-2020) (K MT)
Table 42. Europe Apixaban Sales Market Share by Type (2015-2020)
Table 43. Europe Apixaban Sales by Application (2015-2020) (K MT)
Table 44. Europe Apixaban Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Apixaban Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Apixaban Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Apixaban Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Apixaban Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Apixaban Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Apixaban Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Apixaban Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Apixaban Sales Market Share by Application (2015-2020)
Table 53. Latin America Apixaban Sales by Country (2015-2020) (K MT)
Table 54. Latin America Apixaban Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Apixaban Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Apixaban Revenue Market Share by Country (2015-2020)
Table 57. Latin America Apixaban Sales by Type (2015-2020) (K MT)
Table 58. Latin America Apixaban Sales Market Share by Type (2015-2020)
Table 59. Latin America Apixaban Sales by Application (2015-2020) (K MT)
Table 60. Latin America Apixaban Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Apixaban Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Apixaban Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Apixaban Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Apixaban Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Apixaban Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Apixaban Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Apixaban Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Apixaban Sales Market Share by Application (2015-2020)
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Major Businesses
Table 71. Pfizer Apixaban Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Pfizer Product
Table 73. Pfizer Recent Development
Table 74. Medichem Corporation Information
Table 75. Medichem Description and Major Businesses
Table 76. Medichem Apixaban Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Medichem Product
Table 78. Medichem Recent Development
Table 79. Polpharma Corporation Information
Table 80. Polpharma Description and Major Businesses
Table 81. Polpharma Apixaban Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Polpharma Product
Table 83. Polpharma Recent Development
Table 84. Beijing Cooperate Pharmaceutical Corporation Information
Table 85. Beijing Cooperate Pharmaceutical Description and Major Businesses
Table 86. Beijing Cooperate Pharmaceutical Apixaban Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Beijing Cooperate Pharmaceutical Product
Table 88. Beijing Cooperate Pharmaceutical Recent Development
Table 89. Centaur Pharmaceutical Corporation Information
Table 90. Centaur Pharmaceutical Description and Major Businesses
Table 91. Centaur Pharmaceutical Apixaban Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Centaur Pharmaceutical Product
Table 93. Centaur Pharmaceutical Recent Development
Table 94. DEAFARMA Corporation Information
Table 95. DEAFARMA Description and Major Businesses
Table 96. DEAFARMA Apixaban Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. DEAFARMA Product
Table 98. DEAFARMA Recent Development
Table 99. Dipharma Francis Corporation Information
Table 100. Dipharma Francis Description and Major Businesses
Table 101. Dipharma Francis Apixaban Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Dipharma Francis Product
Table 103. Dipharma Francis Recent Development
Table 104. Global Apixaban Sales Forecast by Regions (2021-2026) (K MT)
Table 105. Global Apixaban Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Apixaban Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Apixaban Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Apixaban Sales Forecast by Country (2021-2026) (K MT)
Table 109. North America: Apixaban Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Apixaban Sales Forecast by Country (2021-2026) (K MT)
Table 111. Europe: Apixaban Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Apixaban Sales Forecast by Region (2021-2026) (K MT)
Table 113. Asia Pacific: Apixaban Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Apixaban Sales Forecast by Country (2021-2026) (K MT)
Table 115. Latin America: Apixaban Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Apixaban Sales Forecast by Country (2021-2026) (K MT)
Table 117. Middle East and Africa: Apixaban Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Apixaban Players
Table 122. Apixaban Customers List
Table 123. Apixaban Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Apixaban Product Picture
Figure 2. Global Apixaban Sales Market Share by Type in 2020 & 2026
Figure 3. Capsule Product Picture
Figure 4. Tablet Product Picture
Figure 5. Global Apixaban Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Online Pharmacy
Figure 9. Apixaban Report Years Considered
Figure 10. Global Apixaban Market Size 2015-2026 (US$ Million)
Figure 11. Global Apixaban Sales 2015-2026 (K MT)
Figure 12. Global Apixaban Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Apixaban Sales Market Share by Region (2015-2020)
Figure 14. Global Apixaban Sales Market Share by Region in 2019
Figure 15. Global Apixaban Revenue Market Share by Region (2015-2020)
Figure 16. Global Apixaban Revenue Market Share by Region in 2019
Figure 17. Global Apixaban Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Apixaban Revenue in 2019
Figure 19. Apixaban Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Apixaban Sales Market Share by Type (2015-2020)
Figure 21. Global Apixaban Sales Market Share by Type in 2019
Figure 22. Global Apixaban Revenue Market Share by Type (2015-2020)
Figure 23. Global Apixaban Revenue Market Share by Type in 2019
Figure 24. Global Apixaban Market Share by Price Range (2015-2020)
Figure 25. Global Apixaban Sales Market Share by Application (2015-2020)
Figure 26. Global Apixaban Sales Market Share by Application in 2019
Figure 27. Global Apixaban Revenue Market Share by Application (2015-2020)
Figure 28. Global Apixaban Revenue Market Share by Application in 2019
Figure 29. North America Apixaban Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Apixaban Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Apixaban Sales Market Share by Country in 2019
Figure 32. North America Apixaban Revenue Market Share by Country in 2019
Figure 33. U.S. Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Apixaban Market Share by Type in 2019
Figure 38. North America Apixaban Market Share by Application in 2019
Figure 39. Europe Apixaban Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Apixaban Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Apixaban Sales Market Share by Country in 2019
Figure 42. Europe Apixaban Revenue Market Share by Country in 2019
Figure 43. Germany Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Apixaban Market Share by Type in 2019
Figure 54. Europe Apixaban Market Share by Application in 2019
Figure 55. Asia Pacific Apixaban Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Apixaban Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Apixaban Sales Market Share by Region in 2019
Figure 58. Asia Pacific Apixaban Revenue Market Share by Region in 2019
Figure 59. China Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Apixaban Market Share by Type in 2019
Figure 82. Asia Pacific Apixaban Market Share by Application in 2019
Figure 83. Latin America Apixaban Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Apixaban Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Apixaban Sales Market Share by Country in 2019
Figure 86. Latin America Apixaban Revenue Market Share by Country in 2019
Figure 87. Mexico Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Apixaban Market Share by Type in 2019
Figure 94. Latin America Apixaban Market Share by Application in 2019
Figure 95. Middle East and Africa Apixaban Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Apixaban Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Apixaban Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Apixaban Revenue Market Share by Country in 2019
Figure 99. Turkey Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Apixaban Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Apixaban Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Apixaban Market Share by Type in 2019
Figure 106. Middle East and Africa Apixaban Market Share by Application in 2019
Figure 107. North America Apixaban Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Apixaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Apixaban Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Apixaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Apixaban Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Apixaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Apixaban Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Apixaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Apixaban Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Apixaban Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
外来患者用調剤自動化の世界市場（～2026年） The outpatient pharmacy automation system is a series of automated computer controlled workflows that minimize errors in pharmaceutical processes such as packaging and distribution. With the growing focus to reduce staffing and cut costs, there is a rise in the adoption of automation in the healthca…- 非滅菌調剤薬の世界市場（～2026年） Nonsterile drug compounding is the practice of preparing specific medication doses for patients to drink, swallow, insert or apply to the skin. It is the most common kind of drug compounding done by pharmacists and pharmacy technicians in community and hospital pharmacies. And despite its "nonsteril…
- 動物用薬剤配合の世界市場（～2026年） Compounding is the mixing of drugs to fit the unique needs of a patient. AHI and AVMA define it as “customized manipulation of an approved drug or drugs by a veterinarian, or by a pharmacist upon the prescription of a veterinarian, to meet the needs of a particular patient. Animal drug shortages are…
- ビタミン欠乏症治療の世界市場（～2026年） Vitamin deficiency, also called as hypovitaminosis, is primarily caused by malnutrition. The global vitamin deficiency treatment market is highly fragmented with large number of local as well as strong players. Market Analysis and Insights: Global Vitamin Deficiency Treatment Market The global Vitam…
- 遠隔薬局の世界市場（～2026年） Telepharmacy is considered to be a way of delivering pharmaceutical products and care by the means of telecommunication to different patients. This way patients can receive their medicines and other pharmaceutical care items in the comfort of where they can get the services easy. Some of the service…